Transactions
Azur Pharma and Burren Pharmaceuticals acquired product rights to Gastrocrom UCB Pharmaceuticals
Jan. 2006
Client: Burren Pharmaceuticals and Azur Pharma are specialty pharmaceutical companies with a primary focus on the acquisition of marketed prescription pharmaceuticals
Role: Edgemont Partners acted as exclusive financial advisor to Burren Pharmaceuticals in the partnering of its exclusive rights to acquire Gastrocrom from UCB Pharma with Azur Pharma
Location: Philadelphia, PA
Sector: Pharmaceutical Services
Lead Banker: David Blume
![azur pharma burren pharma logo](https://edgemont1251.wpenginepowered.com/wp-content/uploads/34-Top-NEW-9-4-15.png)
acquired product rights to Gastrocrom
![ucb pharma logo](https://edgemont1251.wpenginepowered.com/wp-content/uploads/34-Bottom.png)